Mutagenic activation of dibromomethane and diiodomethane by mammalian microsomes and glutathione S-transferases.
The influence of mammalian metabolizing enzymes on the mutagenic activity of dibromomethane and diiodomethane was investigated by using Salmonella typhimurium strain TA100 as indicator. The 2 compounds are known to be metabolized via an oxidative pathway catalysed by microsomal enzymes as well as through direct enzymatic conjugation with glutathione; both pathways possibly give rise to reactive electrophilic intermediates. In mutagenicity plate assays with pre-incubation, dibromo- and diiodo-methane were directly mutagenic towards strain TA100; their mutagenic activity was enhanced upon incubation either with rat-liver microsomes or with the cytosol fraction of the same organ, containing the glutathione S-transferases. These data can be taken as an indication that both microsomal oxidation and conjugation to glutathione are indeed responsible for the mammalian mutagenic activation of dihalomethanes.
D001711:Biotransformation; D005982:Glutathione Transferase / Q000378:metabolism*; D006842:Hydrocarbons, Brominated / Q000378:metabolism*; D006847:Hydrocarbons, Iodinated / Q000378:metabolism*; D008861:Microsomes / Q000378:metabolism*; D009152:Mutagenicity Tests; D009153:Mutagens; D012486:Salmonella typhimurium / Q000235:genetics
D006842:Hydrocarbons, Brominated; D006847:Hydrocarbons, Iodinated; D009153:Mutagens; C027946:methylene iodide; D005982:Glutathione Transferase; C027947:methylene bromide